Market Overview:
The global troponin I test kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiac diseases, technological advancements in troponin I test kits, and rising demand for point-of-care testing. However, the high cost of troponin I test kits may restrain the growth of this market during the forecast period. Based on type, the global troponin I test kit market is segmented into time-resolved immunofluorescence and chemiluminescence immunoassay. The chemiluminescence immunoassay segment is expected to grow at a higher CAGR than the time-resolved immunofluorescence segment during the forecast period. This can be attributed to its advantages such as high sensitivity and specificity, short turnaround time, and low cost as compared with other methods such as enzyme linked immunosorbent assay (ELISA) and radioimmunoassay (RIA).
Product Definition:
A troponin I test kit is a medical device that is used to measure the amount of troponin I in a person's blood. Troponin I is a protein that is found in heart muscle cells. A high level of troponin I can indicate damage to the heart muscle. The importance of measuring troponin I levels is that it can help doctors determine if someone has had a heart attack.
Time-resolved Immunofluorescence:
Time-resolved immunofluorescence (TRIF) is a technique that allows the study of cell biology in real time. It provides high resolution images of cellular components and their interactions at different time points. TRIF has applications in understanding the pathogenesis of diseases, such as cardiomyopathy, by studying cardiac muscle cells under conditions that are not conducive for conventional techniques such as Western Blotting or ELISA.
Chemiluminescence Immunoassay:
Chemiluminescence immunoassay (CLIA) is a technique used for the detection of Troponin I (TnI) in urine and serum samples. It utilizes light energy to detect the presence of TnI, which is an indicator of myocardial infarction.
Application Insights:
Clinics held the largest share of the troponin I test kit market in 2017. This is due to rising awareness about early diagnosis and treatment of lifestyle diseases, growing incidences of cardiac arrest among athletes, and an increase in demand for non-invasive tests. Troponins are used as a biomarker for heart disease & kidney damage during medical emergencies or if symptoms last more than 24 hours. Thus, increasing incidence of cardiac arrest and other heart related disorders coupled with rising awareness regarding these issues is expected to drive segment growth over the forecast period.
Hospital was estimated as the fastest-growing segment owing to factors such as increasing cases of trauma & burn injuries across various regions coupled with government initiatives such as ¢â‚¬Å“Shifting Gears towards Health¢â‚¬ that aims at improving healthcare infrastructure across countries including India, Indonesia, Malaysia and Thailand by 2019.
Regional Analysis:
North America dominated the global troponin I test kit market in 2017. The increasing prevalence of cardiac disorders, rising geriatric population, and high adoption rate of new technologies are some factors responsible for its largest share. Moreover, the presence of well-established healthcare facilities and favorable reimbursement policies are also contributing towards its large share.
Asia Pacific is expected to witness a lucrative CAGR during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding early diagnosis & treatment options for various diseases.
The key players operating in this region include Abbott; Roche Diagnostics Corporation; Bio-Rad Laboratories Inc.; Siemens Healthcare GmbH; Amgen Inc.; American Diagnostica LLC; Aviva Biosciences Pvt Ltd.
Growth Factors:
- Increasing incidence of cardiac diseases: The increasing incidence of cardiac diseases is one of the key growth drivers for the Troponin I Test Kit market. According to a study by the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for 17.3 million deaths in 2015. This number is projected to increase to 23.6 million by 2030. This growing prevalence of cardiac diseases is expected to drive demand for Troponin I Test Kits in the coming years.
- Rising awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment for heart-related conditions, which is expected to boost demand for Troponin I Test Kits in the coming years. Cardiac conditions can often be treated effectively if diagnosed at an early stage, which can help prevent further damage to heart muscles and improve patient outcomes significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Troponin I Test Kit Market Research Report
By Type
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
By Application
Hospital, Clinic
By Companies
Easydiagnosis, Hecin, Innodx, Bioscience, Biosino, Biotests, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Troponin I Test Kit Market Report Segments:
The global Troponin I Test Kit market is segmented on the basis of:
Types
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Easydiagnosis
- Hecin
- Innodx
- Bioscience
- Biosino
- Biotests
- Abbott
Highlights of The Troponin I Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Time-resolved Immunofluorescence
- Chemiluminescence Immunoassay
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Troponin I Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Troponin I Test Kit is a diagnostic tool used to measure troponin levels in the blood. Troponins are proteins that are released from cells during injury or stress, and can be used to determine the severity of a medical condition. The Troponin I Test Kit is often used to diagnose heart attacks, strokes, and other conditions involving the heart or brain.
Some of the key players operating in the troponin i test kit market are Easydiagnosis, Hecin, Innodx, Bioscience, Biosino, Biotests, Abbott.
The troponin i test kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Troponin I Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Troponin I Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Troponin I Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Troponin I Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Troponin I Test Kit Market Size & Forecast, 2020-2028
4.5.1 Troponin I Test Kit Market Size and Y-o-Y Growth
4.5.2 Troponin I Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Time-resolved Immunofluorescence
5.2.2 Chemiluminescence Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Troponin I Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Troponin I Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Time-resolved Immunofluorescence
9.6.2 Chemiluminescence Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Time-resolved Immunofluorescence
10.6.2 Chemiluminescence Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Time-resolved Immunofluorescence
11.6.2 Chemiluminescence Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Time-resolved Immunofluorescence
12.6.2 Chemiluminescence Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Time-resolved Immunofluorescence
13.6.2 Chemiluminescence Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Troponin I Test Kit Market: Competitive Dashboard
14.2 Global Troponin I Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Easydiagnosis
14.3.2 Hecin
14.3.3 Innodx
14.3.4 Bioscience
14.3.5 Biosino
14.3.6 Biotests
14.3.7 Abbott
